CGC Quote, Financials, Valuation and Earnings

Milestone Pharmaceuticals, Inc. has a net margin of -2.46% compared to Canopy Growth Corp.'s net margin of --. Canopy Growth Corp.'s return on equity of -67.7% beat Milestone Pharmaceuticals, Inc.'s return on equity of -858.37%.

Canopy Growth Corp. has a consensus price target of $3.64, signalling upside risk potential of 62.1%. On the other hand Milestone Pharmaceuticals, Inc. has an analysts' consensus of $6.60 which suggests that it could grow by 249.21%. Given that Milestone Pharmaceuticals, Inc. has higher upside potential than Canopy Growth Corp., analysts believe Milestone Pharmaceuticals, Inc. is more attractive than Canopy Growth Corp..

Canopy Growth Corp. has a beta of 0.427, which suggesting that the stock is 57.276% less volatile than S&P 500. In comparison Milestone Pharmaceuticals, Inc. has a beta of 0.439, suggesting its less volatile than the S&P 500 by 56.11%.

Canopy Growth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Milestone Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Canopy Growth Corp. pays -- of its earnings as a dividend. Milestone Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.

Canopy Growth Corp. quarterly revenues are $48.4M, which are larger than Milestone Pharmaceuticals, Inc. quarterly revenues of --. Canopy Growth Corp.'s net income of -$1.2M is higher than Milestone Pharmaceuticals, Inc.'s net income of -$11.9M. Notably, Canopy Growth Corp.'s price-to-earnings ratio is -- while Milestone Pharmaceuticals, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Canopy Growth Corp. is 1.01x versus -- for Milestone Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Oncolytics Biotech, Inc. has a net margin of -2.46% compared to Canopy Growth Corp.'s net margin of --. Canopy Growth Corp.'s return on equity of -67.7% beat Oncolytics Biotech, Inc.'s return on equity of -635.07%.

Canopy Growth Corp. has a consensus price target of $3.64, signalling upside risk potential of 62.1%. On the other hand Oncolytics Biotech, Inc. has an analysts' consensus of $5.52 which suggests that it could grow by 445.61%. Given that Oncolytics Biotech, Inc. has higher upside potential than Canopy Growth Corp., analysts believe Oncolytics Biotech, Inc. is more attractive than Canopy Growth Corp..

Canopy Growth Corp. has a beta of 0.427, which suggesting that the stock is 57.276% less volatile than S&P 500. In comparison Oncolytics Biotech, Inc. has a beta of 0.973, suggesting its less volatile than the S&P 500 by 2.717%.

Canopy Growth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oncolytics Biotech, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Canopy Growth Corp. pays -- of its earnings as a dividend. Oncolytics Biotech, Inc. pays out -- of its earnings as a dividend.

Canopy Growth Corp. quarterly revenues are $48.4M, which are larger than Oncolytics Biotech, Inc. quarterly revenues of --. Canopy Growth Corp.'s net income of -$1.2M is higher than Oncolytics Biotech, Inc.'s net income of -$10.5M. Notably, Canopy Growth Corp.'s price-to-earnings ratio is -- while Oncolytics Biotech, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Canopy Growth Corp. is 1.01x versus -- for Oncolytics Biotech, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Tilray Brands, Inc. has a net margin of -2.46% compared to Canopy Growth Corp.'s net margin of -20%. Canopy Growth Corp.'s return on equity of -67.7% beat Tilray Brands, Inc.'s return on equity of -98.18%.

Canopy Growth Corp. has a consensus price target of $3.64, signalling upside risk potential of 62.1%. On the other hand Tilray Brands, Inc. has an analysts' consensus of $11.83 which suggests that it could grow by 55.18%. Given that Canopy Growth Corp. has higher upside potential than Tilray Brands, Inc., analysts believe Canopy Growth Corp. is more attractive than Tilray Brands, Inc..

Canopy Growth Corp. has a beta of 0.427, which suggesting that the stock is 57.276% less volatile than S&P 500. In comparison Tilray Brands, Inc. has a beta of 1.775, suggesting its more volatile than the S&P 500 by 77.493%.

Canopy Growth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tilray Brands, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Canopy Growth Corp. pays -- of its earnings as a dividend. Tilray Brands, Inc. pays out -- of its earnings as a dividend.

Canopy Growth Corp. quarterly revenues are $48.4M, which are smaller than Tilray Brands, Inc. quarterly revenues of $217.5M. Canopy Growth Corp.'s net income of -$1.2M is higher than Tilray Brands, Inc.'s net income of -$43.5M. Notably, Canopy Growth Corp.'s price-to-earnings ratio is -- while Tilray Brands, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Canopy Growth Corp. is 1.01x versus 0.92x for Tilray Brands, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Venus Concept, Inc. has a net margin of -2.46% compared to Canopy Growth Corp.'s net margin of -163.68%. Canopy Growth Corp.'s return on equity of -67.7% beat Venus Concept, Inc.'s return on equity of -1236.95%.

Canopy Growth Corp. has a consensus price target of $3.64, signalling upside risk potential of 62.1%. On the other hand Venus Concept, Inc. has an analysts' consensus of -- which suggests that it could grow by 9536.36%. Given that Venus Concept, Inc. has higher upside potential than Canopy Growth Corp., analysts believe Venus Concept, Inc. is more attractive than Canopy Growth Corp..

Canopy Growth Corp. has a beta of 0.427, which suggesting that the stock is 57.276% less volatile than S&P 500. In comparison Venus Concept, Inc. has a beta of -0.041, suggesting its less volatile than the S&P 500 by 104.127%.

Canopy Growth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Venus Concept, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Canopy Growth Corp. pays -- of its earnings as a dividend. Venus Concept, Inc. pays out -- of its earnings as a dividend.

Canopy Growth Corp. quarterly revenues are $48.4M, which are larger than Venus Concept, Inc. quarterly revenues of $13.8M. Canopy Growth Corp.'s net income of -$1.2M is higher than Venus Concept, Inc.'s net income of -$22.5M. Notably, Canopy Growth Corp.'s price-to-earnings ratio is -- while Venus Concept, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Canopy Growth Corp. is 1.01x versus 0.02x for Venus Concept, Inc.. Usually stocks with elevated PS ratios are considered overvalued.